Biogen to buy the retinal gene-therapy maker Nightstar
Saturday, March 9, 2019 - 08:10
in Mathematics & Economics
The $800 million purchase is the third gene-therapy acquisition announced in a week
The $800 million purchase is the third gene-therapy acquisition announced in a week